Gao J, De B P, Han Y, Choudhary S, Ransohoff R, Banerjee A K
Department of Virology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
J Virol. 2001 Feb;75(3):1124-31. doi: 10.1128/JVI.75.3.1124-1131.2001.
Human parainfluenza virus type 3 (HPIV3) is one of the major causes of bronchiolitis, pneumonia, and croup in newborns and infants. Cellular immunity involving major histocompatibility complex (MHC) class I and class II molecules plays an important role in controlling virus infection. Several viruses have been shown to down-regulate gamma interferon (IFN-gamma)-mediated MHC class II expression. In this communication, we show that HPIV3 strongly inhibits the IFN-gamma-induced MHC class II expression in HT1080 human fibrosarcoma cells. The culture supernatant of HPIV3-infected cells also inhibited IFN-gamma-induced MHC class II expression, a phenomenon that was found to be due, in large part, to alpha/beta interferon (IFN-alpha/beta). Expression of MHC class I and intercellular adhesion molecule 1 occurred efficiently in cells simultaneously infected with HPIV3 and treated with IFN-gamma, indicating that the inhibitory effect of HPIV3 was specific to MHC class II. STAT1 activation was not affected by HPIV3 at early postinfection times but was partially inhibited at later times. These data suggested that the potent inhibition of MHC class II expression was, in major part, due to a defect downstream of STAT1 activation in the IFN-gamma-induced MHC class II expression pathway. Class II transactivator (CIITA) is the unique mediator of IFN-gamma-induced transcription from the MHC class II promoter. By RNase protection analysis, CIITA expression was found to be strongly inhibited in HPIV3-infected cells. The culture supernatant containing IFN-alpha/beta, on the other hand, inhibited MHC class II expression without affecting STAT1 and CIITA expression. These data indicate that HPIV3 inhibits IFN-gamma-induced MHC class II expression primarily by the viral gene products targeting CIITA and additionally by inducing IFN-alpha/beta to target one or more steps further downstream.
人副流感病毒3型(HPIV3)是新生儿和婴儿毛细支气管炎、肺炎及哮吼的主要病因之一。涉及主要组织相容性复合体(MHC)I类和II类分子的细胞免疫在控制病毒感染中起重要作用。已有几种病毒被证明可下调γ干扰素(IFN-γ)介导的MHC II类分子表达。在本报告中,我们发现HPIV3强烈抑制HT1080人纤维肉瘤细胞中IFN-γ诱导的MHC II类分子表达。HPIV3感染细胞的培养上清液也抑制IFN-γ诱导的MHC II类分子表达,这一现象在很大程度上被发现是由于α/β干扰素(IFN-α/β)所致。MHC I类分子和细胞间黏附分子1在同时感染HPIV3并经IFN-γ处理的细胞中有效表达,表明HPIV3的抑制作用对MHC II类分子具有特异性。STAT1激活在感染后早期不受HPIV3影响,但在后期受到部分抑制。这些数据表明,MHC II类分子表达的有效抑制在很大程度上是由于IFN-γ诱导的MHC II类分子表达途径中STAT1激活下游存在缺陷。II类反式激活因子(CIITA)是IFN-γ诱导MHC II类启动子转录的唯一介导因子。通过核糖核酸酶保护分析发现,CIITA表达在HPIV3感染的细胞中受到强烈抑制。另一方面,含有IFN-α/β的培养上清液在不影响STAT1和CIITA表达的情况下抑制MHC II类分子表达。这些数据表明,HPIV3抑制IFN-γ诱导的MHC II类分子表达主要是通过病毒基因产物靶向CIITA,另外还通过诱导IFN-α/β靶向更下游的一个或多个步骤。